- Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2BIt's becoming Hengrui Pharma's world, and some Western drugmakers are just living in it. China's largest pharma company, which boasts one of the biggest pipelines in the industry, has lined up Br…Endpoints · 2mo ago↗ source
- Optum Rx unveils pharmacy model with clear fees, building on transparency pushUnitedHealth Group’s Optum Rx on Monday unveiled a new approach to prescription drug benefits that it said offers its customers transparency into the entire drug supply chain. Under the new model…Endpoints · 2mo ago↗ source
- Rezdiffra is exceeding Wall Street's expectations as the MASH market takes shapeIt seems there’s room for two in the MASH market. When Novo Nordisk’s blockbuster weight loss drug Wegovy won approval in August 2025 to treat the fatty liver disease, some investors thought it w…